Active substance
Calcium gluconate
- SFDA 5
- US FDA 13
- Health Canada 5
- NHS prices 1
- WHO EML 2
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| 1% CALCIUM GLUCONATE intravenous infusion BP | 1 % | Solution for infusion · Intravenous use | 1 Bag | SAR 14.50 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| CALCIUM GLUCONATE 10% AMP | 10 % | Solution for injection · Intravenous use | 20 Ampoule | SAR 50.25 | Generic · Prescription | B. BRAUN | Valid |
| CALCIUM GLUCONATE 10% W-V INJECTION | 10 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 3.70 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| CALCIUM GLUCONATE 10% W-V INJECTION | 10 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 4.40 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| CALCIUM GLUCONATE 10% W-V INJECTION | 10 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 6.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
Indications — CHI Daman Drug Formulary
ANESTHESIA-SUPPORTIVE AGENTS/ CARDIAC ARREST, CARDIOVASCULAR EMERGENCIES AND/OR DYSRHYTHMIAS; BURN MANAGEMENT; HYPOPARATHYROIDISM; PEDIATRIC B-CELL LYMPHOMA; PRE-ECLAMPSIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CALCIUM GLUCONATE | 1GM/10ML (100MG/ML); 5GM/50ML (100MG/ML); 10GM/100ML (100MG/ML) | solution · intravenous | FRESENIUS KABI USA | Prescription | 15 Jun 2017 |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 1GM/50ML (20MG/ML); 2GM/100ML (20MG/ML); 1GM/100ML (10MG/ML) | solution · intravenous | HQ SPCLT PHARMA | Prescription | 29 Oct 2018 |
| CALCIUM GLUCONATE | 10GM/100ML (100MG/ML) | solution · intravenous | HQ SPCLT PHARMA | Prescription | 29 Oct 2018 |
| CALCIUM GLUCONATE | 1GM/10ML (100MG/ML); 5GM/50ML (100MG/ML); 10GM/100ML (100MG/ML) | solution · intravenous | NIVAGEN | Prescription | 14 Oct 2022 |
| CALCIUM GLUCONATE | 10GM/100ML (100MG/ML) | solution · intravenous | B BRAUN MEDICAL | Prescription | 21 Aug 2023 |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 1GM/50ML (20MG/ML); 2GM/100ML (20MG/ML) | solution · intravenous | AMNEAL | Prescription | 5 Sep 2023 |
| CALCIUM GLUCONATE | 5GM/50ML (100MG/ML); 10GM/100ML (100MG/ML) | solution · intravenous | SOMERSET | Prescription | 19 Oct 2023 |
| CALCIUM GLUCONATE | 1GM/10ML (100MG/ML); 5GM/50ML (100MG/ML); 10GM/100ML (100MG/ML) | solution · intravenous | AMNEAL | Prescription | 10 May 2024 |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 1GM/50ML (20MG/ML); 2GM/100ML (20MG/ML) | solution · intravenous | SAGENT | Prescription | 30 Dec 2025 |
| CALCIUM GLUCONATE | 1GM/10ML (100MG/ML); 5GM/50ML (100MG/ML); 10GM/100ML (100MG/ML) | solution · intravenous | CAPLIN | Prescription | 4 May 2026 |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 1GM/50ML (20MG/ML); 2GM/100ML (20MG/ML) | solution · intravenous | MILLA PHARMS | Prescription | 28 Aug 2026 |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 1GM/50ML (20MG/ML); 2GM/100ML (20MG/ML) | solution · intravenous | CIPLA | Prescription | 17 Sep 2026 |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE | 1GM/50ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2GM/100ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · intravenous | FRESENIUS KABI USA | Discontinued | 15 Jun 2017 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| 2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION | 02538644 | 20 MG / ML | SOLUTION · INTRAVENOUS | FRESENIUS KABI CANADA LTD |
| CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION | 02556871 | 20 MG / ML | SOLUTION · INTRAVENOUS | STERIMAX INC |
| CALCIUM GLUCONATE INJECTION USP 10% | 02555042 | 100 MG / ML | SOLUTION · INTRAVENOUS | STERIMAX INC |
| CALCIUM GLUCONATE INJECTION, USP 10% | 02141019 | 100 MG / ML | SOLUTION · INTRAVENOUS | FRESENIUS KABI CANADA LTD |
| CALCIUM GLUCONATE INJECTION, USP 10% | 02523140 | 100 MG / ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Calcium gluconate 1g effervescent tablets | £18.35 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 27. Vitamins and minerals · complementary
Tetany due to acute calcium deficiency
Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule - 4.2. Antidotes and other substances used in poisonings > Specific · core
Hypermagnesaemia
Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule or vial (10%)
Safety signals and safety-related labeling changes
- US FDA 29 Dec 2021 CALCIUM GLUCONATE — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Combinations containing Calcium gluconate
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.